Prospective Follow-up, Marathon, Long Term, Inflammation and Cardiovascular System (Pro-MagIC)

March 11, 2020 updated by: Johannes Scherr, Technical University of Munich

Prospective Long Term Follow-up Analysis of Exercise-induced Physiological Changes in Male Runners

Pro-MagIC is a prospective observational study and includes participants of the Be-MaGIC-Study 2009 (n=277/NCT00933218). We aim to detect exercise-induced physiological changes (inter alia of the cardiovascular system) induced by repetitive ultra-endurance strain over a period of 10 years.

Study Overview

Status

Unknown

Detailed Description

Physical activity is associated with health benefits. Acute prolonged and strenuous exercise, i.e. Marathon running, leads to hemodynamic, endothelial and myocardial functional changes. Whether these myocardial, endothelial and hemodynamic changes can also develop and persist through repetitive extreme and prolonged physical activity is currently still a matter of controversy. In addition, it is not known whether adaptations and changes over time can develop into clinically relevant cardiovascular events with negative health consequences in healthy athletes. The aim of this study is to detect exercise-induced physiological changes (inter alia of the cardiovascular system) induced by repetitive ultra-endurance strain over a period of 10 years.

For this purpose, 277 male participants from the Be-MaGIC study (Marathon 2009) are examined in this prospective observational study. A single examination with the following components will take place: Anthropometry, clinical examination, laboratory, resting / exercise electrocardiography cardiopulmonary stress test, echocardiography, and fundus camera. Further examinations will be conducted in participants with abnormal examination results in line with current clinical recommendations.

Study Type

Observational

Enrollment (Anticipated)

277

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Participants of the Be-MaGIC-Study (2009)

Description

Inclusion Criteria:

Declaration of consent Participants must have participated in the Be-MaGIC study in 2009

  • current age: 30 - 70 years
  • sex: male

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of right ventricular systolic function (RV-EF)
Time Frame: 10 years
Echocardiography
10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in left ventricular ejection fraction (LV-EF)
Time Frame: 10 years
Echocardiography
10 years
Changes in left ventricular diastolic function (E/e´)
Time Frame: 10 years
Echocardiography
10 years
Change in cardiac markers (e.g. cardiac Troponin)
Time Frame: 10 years
Clinical chemistry (blood samples)
10 years
Change in inflammation markers (e.g. C-reactive Protein)
Time Frame: 10 years
Clinical chemistry (blood samples)
10 years
Change in microcirculation (e.g. arteriolar-to-venular ratio)
Time Frame: 10 years
Static Retinal Vessel Analyzer
10 years
Change in macrocirculation (e.g. Intima media thickness)
Time Frame: 10 years
Carotid sonography
10 years
Change of prevalence of cardiovascular diseases
Time Frame: 10 years
Questionnaire
10 years
Association between changes of aforementioned parameters (see Topics 1-8) and potential underlying causes (e.g. sports history like number of ultraendurance competitions) in the examined cohort
Time Frame: 10 years
10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Michael Schindler, MD, Department of Prevention, Rehabilitation and Sports Medicine, Munich, Germany
  • Principal Investigator: Johannes Scherr, MD, University Hospital Balgrist, University Zurich, Switzerland
  • Study Director: Martin Halle, MD, Department of Prevention, Rehabilitation and Sports Medicine, Munich, Germany

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 15, 2019

Primary Completion (ANTICIPATED)

March 1, 2020

Study Completion (ANTICIPATED)

December 1, 2020

Study Registration Dates

First Submitted

November 13, 2019

First Submitted That Met QC Criteria

November 14, 2019

First Posted (ACTUAL)

November 18, 2019

Study Record Updates

Last Update Posted (ACTUAL)

March 13, 2020

Last Update Submitted That Met QC Criteria

March 11, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • ProMagIC-Study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Participants of the Be-MaGIC-Study 2009

3
Subscribe